Evidence map›Paper›PMID 32336005›Full record

ArticleVeterinary and comparative oncology2020

Prognostic significance of immunohistochemical markers and histological classification in malignant canine mammary tumours.

Nieves Pastor, Luis Javier Ezquerra, Massimo Santella, Nuria C Caballé, Raquel Tarazona, María Esther Durán

Abstract read
In one paragraph

Article in Veterinary and comparative oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Is PTEN rs397510595 an Unexpected Guardian in Canine Mammary Neoplasia?International journal of molecular sciences · 2025
    Article
  5. Article
  6. Low-Invasive Biomarkers of Canine Mammary Tumours.Veterinary medicine and science · 2025
    Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Observational
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Nieves PastorVeterinary Teaching Hospital, University of Extremadura, Cáceres, Spain.
Luis Javier EzquerraAnimal Medicine and Surgery Unit, Department of Animal Medicine, Faculty of Veterinary Medicine, University of Extremadura, Cáceres, Spain.
Massimo SantellaVeterinary Teaching Hospital, University of Extremadura, Cáceres, Spain.
Nuria C CaballéDepartment of Physics and Mathematics, University of Alcalá, Science Faculty, Alcalá de Henares, Spain.
Raquel TarazonaImmunology Unit, Department of Physiology, Faculty of Veterinary Medicine, University of Extremadura, Cáceres, Spain.ORCID https://orcid.org/0000-0002-2926-6377
María Esther DuránAnatomy and Comparative Pathological Anatomy, Department of Animal Medicine, Faculty of Veterinary Medicine, University of Extremadura, Cáceres, Spain.

Funding

European Regional Development FundJunta de Extremadura, Spain GR18085 GR18020Ministerio de Economía y Competitividad of Spain MTM2015-63978-P
6 · The paper itself

Abstract

Canine mammary carcinoma represents a model for the study of human breast cancer, although the prognostic value of various clinical, histological and immunohistochemical parameters has shown contradictory results. A prospective study, through a 4-year follow-up, was performed in 77 patients with mammary carcinoma to analyse the association between histological diagnosis, grade of malignancy, peritumoral and vascular invasion. We have also performed immunohistochemistry for the expression of oestrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (HER2) and cyclooxygenase-2 (COX-2) that define human biomarkers of disease progression and treatment response. An association between histological diagnosis and clinical stage was observed with a high proportion of complex carcinoma classified as stage I. There was a higher proportion of ER

Indexed as

AnimalsBiomarkers, TumorCarcinomaCyclooxygenase 2Dog DiseasesDogsErbB ReceptorsFemaleImmunohistochemistryMammary Neoplasms, AnimalNeoplasm MetastasisNeoplasm StagingPrognosisProspective StudiesReceptors, EstrogenReceptors, ProgesteroneBiomarkers, TumorCyclooxygenase 2ErbB ReceptorsReceptors, EstrogenReceptors, Progesteronecanine mammary carcinomahistological classificationimmunohistochemistrypathologyprognosis

Identifiers

PMID32336005
PMCPMC7754150

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.